<DOC>
	<DOCNO>NCT02675751</DOCNO>
	<brief_summary>Prospective , multicenter , bilaterally-treated , open-label , non-randomized clinical trial .</brief_summary>
	<brief_title>Prospective S &amp; E Study Wavefront-guided PRK Myopia With iDesign Advanced Wavescan Studio™ System Star S4 IR™</brief_title>
	<detailed_description />
	<mesh_term>Astigmatism</mesh_term>
	<mesh_term>Refractive Errors</mesh_term>
	<criteria>NOTE : Enrollment open military personnel Signed informed consent HIPAA authorization . Refractive error , base iDesign display refraction must myopia without astigmatism sphere 8.00 D , cylinder 0.00 D 4.00 D maximum SE 10.00 D. Anticipated residual stromal bed thickness least 250 micron calculate iDesign system . Distance Best Spectacle Corrected Visual Acuity ( BSCVA ) 20/20 good BSCVA ≥2 line ( ≥10 letter ) good distance Uncorrected Visual Acuity ( UCVA ) . Less equal 0.75 D difference cycloplegic manifest refraction sphere . Stable refractive error define change ≤1.00 D MRSE least 12 month time period . Any subject eye history contact lens wear within last 4 week must demonstrate refractive stability Agreement manifest refraction ( adjusted optical infinity ) iDesign System refraction choose treatment . Willing capable comply followup examination duration study . Women pregnant , breastfeeding , intend become pregnant , use adequate method birth control . Concurrent use systemic ( include inhale ) medication may impair heal . History follow medical condition , condition could affect wound healing : collagen vascular disease , autoimmune disease , immunodeficiency disease , ocular herpes zoster herpes simplex , endocrine disorder ( include , limited unstable thyroid disorder diabetes ) , lupus , rheumatoid arthritis . Subjects cardiac pacemaker , implanted defibrillator implant electronic device . History prior intraocular corneal surgery , active ophthalmic disease abnormality , retinal detachment/repair , clinically significant lens opacity , clinical evidence trauma , corneal opacity within central 9 mm visible topography , risk develop strabismus , evidence glaucoma propensity narrow angle glaucoma . Evidence keratoconus , corneal dystrophy irregularity , abnormal topography Known sensitivity inappropriate responsiveness medication use study . If either eye meet inclusion criterion Desire monovision . Participation clinical study , exception fellow eye study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>myopia</keyword>
</DOC>